These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11288983)
1. Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Bièche I; Franc B; Vidaud D; Vidaud M; Lidereau R Thyroid; 2001 Feb; 11(2):147-52. PubMed ID: 11288983 [TBL] [Abstract][Full Text] [Related]
2. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397 [TBL] [Abstract][Full Text] [Related]
4. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions. Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction. Egawa C; Miyoshi Y; Iwao K; Shiba E; Noguchi S Oncology; 2001; 61(4):293-8. PubMed ID: 11721176 [TBL] [Abstract][Full Text] [Related]
7. Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomas. Zou M; Shi Y; Farid NR; al-Sedairy ST Endocrine; 1998 Feb; 8(1):61-4. PubMed ID: 9666346 [TBL] [Abstract][Full Text] [Related]
8. [Morphologic and molecular-genetic characteristics of carcinoma, adenoma and surrounding tissue of the thyroid gland]. Pal'tsev MA; Kogan EA; Tuntsova OI; Severin ES; Silaeva SA; Golenchenko VA Arkh Patol; 1998; 60(3):5-10. PubMed ID: 9702292 [TBL] [Abstract][Full Text] [Related]
9. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA measurement in benign and malignant human thyroid tissues. Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468 [TBL] [Abstract][Full Text] [Related]
12. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790 [TBL] [Abstract][Full Text] [Related]
13. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma]. Yang Y Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490 [TBL] [Abstract][Full Text] [Related]
14. Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific-differential display: decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors. Maeda I; Takano T; Matsuzuka F; Maruyama T; Higashiyama T; Liu G; Kuma K; Amino N Int J Cancer; 1999 May; 81(5):700-4. PubMed ID: 10328219 [TBL] [Abstract][Full Text] [Related]
15. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Lacroix L; Nocera M; Mian C; Caillou B; Virion A; Dupuy C; Filetti S; Bidart JM; Schlumberger M Thyroid; 2001 Nov; 11(11):1017-23. PubMed ID: 11762710 [TBL] [Abstract][Full Text] [Related]
16. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas. Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032 [TBL] [Abstract][Full Text] [Related]
17. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction. Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598 [TBL] [Abstract][Full Text] [Related]
18. Relationship between the level of c-myc mRNA and histologic aggressiveness in thyroid tumors. Romano MI; Grattone M; Karner MP; Moiguer S; Tetelbaum F; Romano LA; Illescas E; Padin R; Cueva F; Burdman JA Horm Res; 1993; 39(3-4):161-5. PubMed ID: 8262479 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Bièche I; Olivi M; Noguès C; Vidaud M; Lidereau R Br J Cancer; 2002 Feb; 86(4):580-6. PubMed ID: 11870541 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. Stolf BS; Carvalho AF; Martins WK; Runza FB; Brun M; Hirata R; Jordão Neves E; Soares FA; Postigo-Dias J; Kowalski LP; Reis LF Cancer Lett; 2003 Mar; 191(2):193-202. PubMed ID: 12618333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]